Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitors

被引：83

作者：

Eary, C. Todd ^{[1
]}

Jones, Zachary S. ^{[1
]}

Groneberg, Robert D. ^{[1
]}

Burgess, Laurence E. ^{[1
]}

Mareska, David A. ^{[1
]}

Drew, Mark D. ^{[1
]}

Blake, James F. ^{[1
]}

Laird, Ellen R. ^{[1
]}

Balachari, Devan ^{[1
]}

O'Sullivan, Michael ^{[1
]}

Allen, Andrew ^{[1
]}

Marsh, Vivienne ^{[1
]}

机构：

[1] Array BioPharma, Boulder, CO 80301 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 09期

关键词：

cholesteryl ester transfer protein; CETP; HDL; tetrahydoquinoxalines; cholesterol;

D O I：

10.1016/j.bmcl.2007.01.112

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Cholesteryl ester transfer protein is a plasma glycoprotein that transfers cholesterol ester between lipoprotein particles. Inhibition of this protein, in vitro and in vivo, produces an increase in plasma high density lipoprotein cholesterol (HE)L-Q. This communication will describe the SAR and svnthesis of a series of substituted tetrahydroquinoxaline CETP inhibitors from early P lead to advanced enantiomerically pure anaiogs. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：2608 / 2613

页数：6

共 50 条

[31] Review of the quantitative analysis of cholesteryl ester transfer protein inhibitors
Mullangi, Ramesh
Srinivas, Nuggehally R.
[J]. BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (10) : 1259 - 1272
[32] Potent Cholesteryl Ester Transfer Protein Inhibitors of Reduced Lipophilicity: 1,1′-Spiro-Substituted Hexahydrofuroquinoline Derivatives
Trieselmann, Thomas
Wagner, Holger
Fuchs, Klaus
Hamprecht, Dieter
Berta, Daniela
Cremonesi, Paolo
Streicher, Ruediger
Luippold, Gerd
Volz, Astrid
Markert, Michael
Nar, Herbert
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (21) : 8766 - 8776
[33] Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors
Liu, Shenping
Mistry, Anil
Reynolds, Jennifer M.
Lloyd, David B.
Griffor, Matthew C.
Perry, David A.
Ruggeri, Roger B.
Clark, Ronald W.
Qiu, Xiayang
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (44) : 37321 - 37329
[34] Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
Mabuchi, Hiroshi
Nohara, Atsushi
Inazu, Akihiro
[J]. MOLECULES AND CELLS, 2014, 37 (11) : 777 - 784
[35] Present therapeutic role of cholesteryl ester transfer protein inhibitors
Ferri, Nicola
Corsini, Alberto
Sirtori, Cesare R.
Ruscica, Massimiliano
[J]. PHARMACOLOGICAL RESEARCH, 2018, 128 : 29 - 41
[36] QSAR STUDY OF A SERIES OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
Chhabria, Mahesh T.
Suhagia, Bhanubhai N.
Mandhare, Appaji B.
Brahmkshatriya, Pathik S.
[J]. COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2011, 76 (07) : 803 - 813
[37] Cholesteryl Ester Transfer Protein Inhibitors Future Soon to be REVEALed
Huggins, Christopher
Charolidi, Nicoletta
Cockerill, Gillian W.
[J]. EUROPEAN CARDIOLOGY REVIEW, 2015, 10 (01) : 64 - 67
[38] Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
Goldberg, Alyse S.
Hegele, Robert A.
[J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 251 - 259
[39] CHOLESTERYL ESTER ANALOGS INHIBIT CHOLESTERYL ESTER BUT NOT TRIGLYCERIDE TRANSFER CATALYZED BY THE PLASMA CHOLESTERYL ESTER-TRIGLYCERIDE TRANSFER PROTEIN
BUSCH, SJ
HARMONY, JAK
[J]. LIPIDS, 1990, 25 (04) : 216 - 220
[40] Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
Chapman, M. John
Le Goff, Wilfried
Guerin, Maryse
Kontush, Anatol
[J]. EUROPEAN HEART JOURNAL, 2010, 31 (02) : 149 - 164

← 1 2 3 4 5 →